Bedrijfsvoering Abbott Laboratories

Aandelen

ABT

US0028241000

Medische apparatuur, benodigdheden & distributie

Geschatte realtime Cboe BZX 21:23:10 06-02-2025 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
128,84 USD -2,43% Intraday-grafiek van Abbott Laboratories +0,04% +13,92%

Uitvoerend comité: Abbott Laboratories

Bedrijfsleider
Beklede functiesVan
Robert Ford

Robert Ford

51 jaar

Chief Executive Officer 31-03-2020
Chief Operating Officer 15-10-2018
President 15-10-2018
Melissa Brotz

Melissa Brotz

Public Communications Contact -
Sales & Marketing -
John McCoy

John McCoy

55 jaar

Comptroller/Controller/Auditor 01-09-2023
Scott House

Scott House

Chief Tech/Sci/R&D Officer 01-03-2020
General Counsel 01-03-2020
Philip Boudreau

Philip Boudreau

52 jaar

Director of Finance/CFO 01-09-2023
Mary Moreland

Mary Moreland

58 jaar

Human Resources Officer 01-08-2019
Kathryn Collins

Kathryn Collins

General Counsel 01-01-1999
Hubert Allen

Hubert Allen

59 jaar

General Counsel 01-01-2013
Corporate Secretary 01-01-2013
Alison Davies

Alison Davies

56 jaar

Treasurer 01-09-2023

Samenstelling van de raad van bestuur: Abbott Laboratories

Directeur
RadenVan
Robert Ford

Robert Ford

51 jaar

Executive Committee Chair 10-12-2021
Nancy McKinstry

Nancy McKinstry

66 jaar

Executive Committee 09-12-2011
Compensation Committee 09-12-2011
Audit Committee Chair
Governance Committee 13-07-2016
Nominating Committee 13-07-2016
Compensation Committee Chair 13-07-2016
HR Committee Chair
John Stratton

John Stratton

64 jaar

Audit Committee 05-02-2020
Executive Committee
Governance Committee Chair
Nominating Committee Chair
Finance Committee 05-02-2020
Michelle Kumbier

Michelle Kumbier

58 jaar

Audit Committee 20-10-2020
Compensation Committee 08-06-2018
Compensation Committee Chair 20-10-2020
HR Committee Chair 20-10-2020
Michael O'Grady

Michael O'Grady

59 jaar

Executive Committee Chair
Compensation Committee
Governance Committee 28-04-2023
Nominating Committee 28-04-2023
Darren McDew

Darren McDew

64 jaar

Governance Committee 30-03-2023
Nominating Committee 09-09-2019
Audit Committee 01-01-2019
Compensation Committee
Paola Gonzalez

Paola Gonzalez

53 jaar

Audit Committee 30-08-2021
Governance Committee 30-08-2021
Nominating Committee 30-08-2021
Robert Alpern

Robert Alpern

74 jaar

Governance Committee
Nominating Committee
Sally Blount

Sally Blount

63 jaar

Governance Committee 20-02-2013
Nominating Committee 20-02-2013
Daniel Starks

Daniel Starks

70 jaar

Executive Committee
Compensation Committee Chair
Michael Roman

Michael Roman

65 jaar

Executive Committee
Compensation Committee 23-04-2021
Claire Babineaux-Fontenot

Claire Babineaux-Fontenot

60 jaar

Audit Committee

Voormalige zaakvoerders en bestuurders: Abbott Laboratories

Insider
Beklede functies
VanTot
Robert Funck
Robert Funck
Comptroller/Controller/Auditor 01-01-2013 01-03-2020
Compliance Officer 01-01-2009 01-01-2013
Director of Finance/CFO 01-03-2020 01-09-2023
Corporate Officer/Principal 01-09-2023 01-07-2024
Treasurer 01-01-2005 01-01-2007
Roxanne Austin
Roxanne Austin
Director/Board Member 01-01-2000 29-04-2022
Independent Dir/Board Member 01-01-2000 29-04-2022
Miles White
Miles White
Director/Board Member 13-02-1998 01-01-1999
Chief Executive Officer 01-01-1999 31-03-2020
Chairman 01-01-1999 10-12-2021
Corporate Officer/Principal 01-01-1984 01-01-1999
Stephen R. Fussell
Stephen R. Fussell
Human Resources Officer 01-01-2005 31-07-2019
Elaine R. Leavenworth
Elaine R. Leavenworth
Public Communications Contact 01-01-1991 -
General Counsel 01-01-1991 23-04-2015
Sales & Marketing 01-12-2014 01-08-2018
Thomas Freyman
Thomas Freyman
Chief Administrative Officer 01-06-2015 01-02-2017
Director of Finance/CFO 01-02-1979 01-06-2015
Preston T. Simons
Preston T. Simons
Chief Tech/Sci/R&D Officer 01-10-2000 01-09-2015
Thomas Joseph Dee
Thomas Joseph Dee
Comptroller/Controller/Auditor 01-01-1990 01-04-2011
Corporate Officer/Principal 01-04-2011 01-09-2013
John B. Thomas
John B. Thomas
Investor Relations Contact 01-12-1995 01-05-2013
Public Communications Contact 01-12-1995 01-05-2013
Greg W. Linder
Greg W. Linder
Comptroller/Controller/Auditor 01-01-1999 28-02-2013
Jaime Contreras
Jaime Contreras
Corporate Officer/Principal - -
Eugene Sun
Eugene Sun
Corporate Officer/Principal 01-01-2000 24-08-2012
Mary Szela
Mary Szela
Corporate Officer/Principal 01-01-2008 01-12-2009
Sales & Marketing 01-01-2010 01-05-2012
Laura Schumacher
Laura Schumacher
General Counsel 01-01-2007 01-01-2012
Corporate Secretary 01-01-2007 01-01-2012
John Leonard
John Leonard
Chief Tech/Sci/R&D Officer 01-01-1992 01-01-2012
Susan M. Widner
Susan M. Widner
Sales & Marketing - 24-08-2011
William Daley
William Daley
Director/Board Member 08-10-2004 07-01-2011
Holger Liepmann
Holger Liepmann
Corporate Officer/Principal 01-01-1986 01-01-2011
Sean Murphy
Sean Murphy
Corporate Officer/Principal 01-01-1979 -
Fang-Tyan Chen
Fang-Tyan Chen
Corporate Officer/Principal 01-01-1988 01-01-2010
Wynetka Ann Reynolds
Wynetka Ann Reynolds
Director/Board Member 01-01-1980 01-01-2010
James Tyree
James Tyree
Corporate Officer/Principal 01-06-1997 01-08-2009
John Walter
John Walter
Director/Board Member 01-01-1990 13-10-2007
Richard Gonzalez
Richard Gonzalez
Chief Operating Officer 01-06-1977 30-09-2007
President 01-06-1977 30-09-2007
Chief Operating Officer 01-10-2012 01-12-2012
Corporate Officer/Principal 02-07-2010 01-10-2012
Jeffrey Binder
Jeffrey Binder
Corporate Officer/Principal 01-01-2006 01-02-2007
Douglas Bryant
Douglas Bryant
Corporate Officer/Principal 01-01-1983 01-01-2007
Jeffrey Leiden
Jeffrey Leiden
Director/Board Member 01-01-2001 27-03-2006
Chief Operating Officer 01-01-2000 27-03-2006
Chief Tech/Sci/R&D Officer 01-01-2000 27-03-2006
President 01-01-2000 27-03-2006
James Farrell
James Farrell
Director/Board Member 16-01-2006 -
Independent Dir/Board Member 16-01-2006 -
A. Barry Rand
A. Barry Rand
Director/Board Member - 15-01-2006
Karen L. Miller
Karen L. Miller
Chief Tech/Sci/R&D Officer - 01-03-2005
Jose M. de Lasa
Jose M. de Lasa
General Counsel - 01-03-2005
Christopher Begley
Christopher Begley
Corporate Officer/Principal 01-01-1998 01-04-2004
Richard W. Ashley
Richard W. Ashley
Corporate Officer/Principal 02-02-2004 -
Donald V. Patton
Donald V. Patton
Corporate Officer/Principal 01-01-2004 -
Joseph M. Nemmers
Joseph M. Nemmers
Corporate Officer/Principal 01-01-2001 -
Alan S. Rosenthal
Alan S. Rosenthal
Chief Tech/Sci/R&D Officer 01-01-1993 01-01-1999
Paul Clark
Paul Clark
Director/Board Member 01-01-1984 01-12-1998
Corporate Officer/Principal 01-01-1984 01-12-1998
Roy S. Roberts
Roy S. Roberts
Director/Board Member 01-01-1998 -
Independent Dir/Board Member 24-03-2011 -
Risa Stack
Risa Stack
Corporate Officer/Principal - 31-12-1996
David A. L. Owen
David A. L. Owen
Director/Board Member 01-01-1996 -
Independent Dir/Board Member 24-03-2011 -
Gary Stevenson
Gary Stevenson
Corporate Officer/Principal 01-09-1988 30-09-1995
Perry Karsen
Perry Karsen
Corporate Officer/Principal 01-01-1983 01-01-1994
O. Ralph Edwards
O. Ralph Edwards
Human Resources Officer - 01-01-1993
Timothy Ring
Timothy Ring
Human Resources Officer 01-01-1983 01-01-1993
Dan Kisner
Dan Kisner
Corporate Officer/Principal 01-01-1988 01-01-1991
H. Fuller
H. Fuller
Director/Board Member 01-01-1988 -
Independent Dir/Board Member 24-03-2011 -
Edward Fiorentino
Edward Fiorentino
Corporate Officer/Principal 01-04-1986 -
Boone Powell
Boone Powell
Director/Board Member 17-08-2010 -
Nelson L. Levy
Nelson L. Levy
Corporate Officer/Principal 01-01-1981 01-01-1984
William D. Smithburg
William D. Smithburg
Director/Board Member 01-01-1982 -
Independent Dir/Board Member 24-03-2011 -
William M. Dwyer
William M. Dwyer
Sales & Marketing 01-01-1977 -
Paul Thorpe
Paul Thorpe
Sales & Marketing - -
Lance B. Wyatt
Lance B. Wyatt
Corporate Officer/Principal - -
Terrence A. Gibbons
Terrence A. Gibbons
Sales & Marketing - -
Ting Oei
Ting Oei
Corporate Officer/Principal - -
Lawrence E. Kraus
Lawrence E. Kraus
Corporate Officer/Principal - -
Mark Masterson
Mark Masterson
Chief Operating Officer 23-11-2009 -
Corporate Officer/Principal - 23-11-2009
Ben Robinson
Ben Robinson
Corporate Officer/Principal - -
Zahir Lavji
Zahir Lavji
Corporate Officer/Principal - 18-11-2009
Sales & Marketing 18-11-2009 -
Roger J. Guidi
Roger J. Guidi
Corporate Officer/Principal - -
Kazumi Shiosaki
Kazumi Shiosaki
Corporate Officer/Principal - -
William D. Smart
William D. Smart
Corporate Officer/Principal - -
Daniel W. Norbeck
Daniel W. Norbeck
Corporate Officer/Principal - -
P. Loreen Mershimer
P. Loreen Mershimer
Corporate Officer/Principal - -
Thomas M. Wascoe
Thomas M. Wascoe
Human Resources Officer - -
Howard Liang
Howard Liang
Chief Tech/Sci/R&D Officer - -
Catherine V. Babington
Catherine V. Babington
Public Communications Contact - -
Michael G. Beatrice
Michael G. Beatrice
Compliance Officer 19-02-2013 -
General Counsel - 19-02-2013
Corporate Officer/Principal 19-02-2013 19-02-2013
Charles M. Brock
Charles M. Brock
General Counsel - -
Aj J. Shoultz
Aj J. Shoultz
Comptroller/Controller/Auditor - -
Howard Zauberman
Howard Zauberman
Corporate Officer/Principal - -

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man 19
Vrouw 11

Waarvan leden van het uitvoerend comité

Man 5
Vrouw 4

Waarvan bestuurders

Man 8
Vrouw 4

Herzieningen

Herziening omzet 1 jaar
-
Herziening omzet 4 maanden
-
Herziening omzet 1 maanden
-
Herziening WPA 1 jaar
-
Herziening WPA 4 maanden
-
ESG MSCI
BB

ESG

Milieu
Sociaal
Bedrijfsvoering
Controverse
ESG: ethische controverses
-
ESG: controverses inzake mensenrechten
-
ESG: Controverses Belastingsubsidies
-
In overeenstemming met islamitisch financieren
-
Logo Abbott Laboratories
Abbott Laboratories is gespecialiseerd in het onderzoek, de ontwikkeling, de vervaardiging en de verkoop van farmaceutische en medische producten. De omzet per productfamilie wordt als volgt onderverdeeld: - diagnosesystemen en -instrumenten (39,1%); - voorzieningen voor de bloedvaten (24,7%): endoprothesesystemen, dilatatiekatheters, sluiting van bloedvaten , enz.; - voedingsproducten (12,1%): producten voor kindervoeding, voedingssupplementen en dieetproducten; - medicijnen (8,2%): verdovende, antivirale, antibiotische, inhiberende, ontstekingremmende producten, enz.; - overige (15,9%). De geografische verdeling van de omzet is als volgt: Verenigde Staten (38,5%), Duitsland (5,8%), China (5,6%), India (4,4%), Zwitserland (4,1%), Japan (3,8%), Nederland (2,7%) en overige (35,1%).
Werknemers
114.000
Meer informatie over het bedrijf

Sleutelfiguren die het bedrijf verlieten

Duane L. Burnham
-
Duane L. Burnham

Chief Executive Officer

12-03-1990 01-01-1999

Miles White
-
Miles White

Chief Executive Officer

01-01-1999 31-03-2020